LHD: 2-[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]ethyl-[[4-azanyl-1-(methoxymethyl)-2-oxidanylidene-pyrimidin-5-yl]methyl]azanium
LHD is a Ligand Of Interest in 5TBJ designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 5TBJ_LHD_C_501 | 55% | 54% | 0.146 | 0.913 | 0.65 | 1.11 | - | 3 | 0 | 0 | 100% | 1 |
| 5TBJ_LHD_B_501 | 38% | 46% | 0.17 | 0.871 | 0.64 | 1.47 | - | 5 | 1 | 0 | 100% | 1 |
| 5TBJ_LHD_D_501 | 37% | 55% | 0.172 | 0.867 | 0.65 | 1.09 | - | 2 | 0 | 0 | 100% | 1 |
| 5TBJ_LHD_A_501 | 36% | 54% | 0.16 | 0.853 | 0.63 | 1.14 | - | 3 | 1 | 0 | 100% | 1 |
